2018 - CARISMA Therapeutics

News & Events

Co-Founder and VP of Discovery Research, Michael Klichinsky, presents at the AACR Tumor Immunology and Immunotherapy meeting.

Co-Founder and VP of Discovery Research, Michael Klichinsky, presents at the 9th Symposium Institut Cochin in Paris, France.

Co-Founder and VP of Discovery Research, Michael Klichinsky, presents at the 25th Annual Scientific Retreat of the Prostate Cancer Foundation.

Carisma Therapeutics CEO, Steven Kelly, travels to sunny San Diego, CA to present at the Cell & Gene Meeting on the Mesa, October 3-5, 2018.

Co-Founders Saar Gill, MD PhD and Michael Klichinsky, PharmD interviewed by Science Magazine on next generation cancer immunotherapies.

Carisma Therapeutics presents at the CAR-TCR Summit in Boston.

Carisma Therapeutics closes a $53Million Series A financing with top investors to develop novel CAR-Macrophage immunotherapies.